<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Am Acad Child Adolesc Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">J Am Acad Child Adolesc Psychiatry</journal-id><journal-title-group><journal-title>Journal of the American Academy of Child and Adolescent Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0890-8567</issn><issn pub-type="epub">1527-5418</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25457928</article-id><article-id pub-id-type="pmc">4305192</article-id><article-id pub-id-type="publisher-id">S0890-8567(14)00664-9</article-id><article-id pub-id-type="doi">10.1016/j.jaac.2014.09.012</article-id><article-categories><subj-group subj-group-type="heading"><subject>New Research</subject></subj-group></article-categories><title-group><article-title>Telephone Cognitive-Behavioral Therapy for Adolescents With Obsessive-Compulsive Disorder: A Randomized Controlled Non-inferiority Trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Turner</surname><given-names>Cynthia M.</given-names></name><degrees>PhD</degrees><email>cynthia.turner@uq.edu.au</email><xref rid="aff1" ref-type="aff">a</xref><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib><contrib contrib-type="author"><name><surname>Mataix-Cols</surname><given-names>David</given-names></name><degrees>PhD</degrees><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Lovell</surname><given-names>Karina</given-names></name><degrees>PhD</degrees><xref rid="aff3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name><surname>Krebs</surname><given-names>Georgina</given-names></name><degrees>DClinPsy</degrees><xref rid="aff4" ref-type="aff">d</xref></contrib><contrib contrib-type="author"><name><surname>Lang</surname><given-names>Katie</given-names></name><degrees>MPhil</degrees><xref rid="aff5" ref-type="aff">e</xref></contrib><contrib contrib-type="author"><name><surname>Byford</surname><given-names>Sarah</given-names></name><degrees>PhD</degrees><xref rid="aff5" ref-type="aff">e</xref></contrib><contrib contrib-type="author"><name><surname>Heyman</surname><given-names>Isobel</given-names></name><degrees>PhD</degrees><xref rid="aff6" ref-type="aff">f</xref></contrib></contrib-group><aff id="aff1"><label>a</label>University of Queensland, Brisbane, Australia</aff><aff id="aff2"><label>b</label>Institute of Psychiatry, Psychology, and Neuroscience, King&#x02019;s College London, and the Karolinska Institutet, Stockholm</aff><aff id="aff3"><label>c</label>School of Nursing, Midwifery and Social Work, University of Manchester, Manchester, UK</aff><aff id="aff4"><label>d</label>Institute of Psychiatry, Psychology, and Neuroscience, King&#x02019;s College London, the OCD and Related Disorders Clinic for Young People, South London, and Maudsley National Health Service (NHS) Foundation Trust, London</aff><aff id="aff5"><label>e</label>Institute of Psychiatry, Psychology, and Neuroscience, King&#x02019;s College London</aff><aff id="aff6"><label>f</label>Institute of Psychiatry, Psychology, and Neuroscience, King&#x02019;s College London, the Great Ormond Street Hospital, London, and the Institute of Child Health, University College London</aff><author-notes><corresp id="cor1"><label>&#x02217;</label>Correspondence to Cynthia Turner, PhD, Child and Family Psychology Clinic, Parenting and Family Support Centre, Department of Psychology, The University of Queensland, Brisbane QLD 4072, Australia <email>cynthia.turner@uq.edu.au</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>1</day><month>12</month><year>2014</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="ppub">.--><pub-date pub-type="ppub"><month>12</month><year>2014</year></pub-date><volume>53</volume><issue>12</issue><fpage>1298</fpage><lpage>1307.e2</lpage><history><date date-type="accepted"><day>25</day><month>9</month><year>2014</year></date></history><permissions><copyright-statement>Crown Copyright &#x000a9; Published by American Academy of Child and Adolescent Psychiatry. All rights reserved.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder/><license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).</license-p></license></permissions><abstract><sec><title>Objective</title><p>Many adolescents with obsessive-compulsive disorder (OCD) do not have access to evidence-based treatment. A randomized controlled non-inferiority trial was conducted in a specialist OCD clinic to evaluate the effectiveness of telephone cognitive-behavioral therapy (TCBT) for adolescents with OCD compared to standard clinic-based, face-to-face CBT.</p></sec><sec><title>Method</title><p>Seventy-two adolescents, aged 11 through 18 years with primary OCD, and their parents were randomized to receive specialist TCBT or CBT. The intervention provided differed only in the method of treatment delivery. All participants received up to 14 sessions of CBT, incorporating exposure with response prevention (E/RP), provided by experienced therapists. The primary outcome measure was the Children&#x02019;s Yale&#x02013;Brown Obsessive-Compulsive Scale (CY-BOCS). Blind assessor ratings were obtained at midtreatment, posttreatment, 3-month, 6-month, and 12-month follow-up.</p></sec><sec><title>Results</title><p>Intent-to-treat analyses indicated that TCBT was not inferior to face-to-face CBT at posttreatment, 3-month, and 6-month follow-up. At 12-month follow-up, there were no significant between-group differences on the CY-BOCS, but the confidence intervals exceeded the non-inferiority threshold. All secondary measures confirmed non-inferiority at all assessment points. Improvements made during treatment were maintained through to 12-month follow-up. Participants in each condition reported high levels of satisfaction with the intervention received.</p></sec><sec><title>Conclusion</title><p>TCBT is an effective treatment and is not inferior to standard clinic-based CBT, at least in the&#x000a0;midterm. This approach provides a means of making a specialized treatment more accessible to many adolescents with OCD. Clinical trial registration information&#x02013;Evaluation of telephone-administered cognitive-behaviour therapy (CBT) for young people with obsessive-compulsive disorder (OCD); <ext-link ext-link-type="uri" xlink:href="http://www.controlled-trials.com;%20ISRCTN27070832" id="intref0010">http://www.controlled-trials.com; ISRCTN27070832</ext-link>.</p></sec></abstract><kwd-group><title>Key Words</title><kwd>OCD</kwd><kwd>psychotherapy</kwd><kwd>CBT</kwd><kwd>telehealth</kwd></kwd-group></article-meta></front><body><p>Obsessive-compulsive disorder (OCD) in children and adolescents is a chronic disorder that can cause functional impairment across multiple life domains.<xref rid="bib1 bib2" ref-type="bibr"><sup>1,2</sup></xref> Estimates suggest that approximately 1 in 100 young persons suffers from OCD.<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref> Cognitive-behavioral therapy (CBT) incorporating exposure and response prevention (E/RP) is the recommended psychological treatment for pediatric OCD.<xref rid="bib4 bib5" ref-type="bibr"><sup>4,5</sup></xref> However, CBT is not readily available to all who need it because of a variety of factors, and geographical and financial barriers prevent many from receiving treatment.</p><p>Telehealth is an area of mental health practice that offers significant potential for improving access to specialized treatments.<xref rid="bib6" ref-type="bibr"><sup>6</sup></xref> Telehealth involves the use of telecommunication tools (e.g., telephone, Internet, video-conferencing) as a means for health professionals to provide treatment remotely. Telehealth applications of psychological treatments have grown in popularity, as they have shown effectiveness<xref rid="bib7" ref-type="bibr"><sup>7</sup></xref> but also offer additional benefits such as reduced time and cost.<xref rid="bib8" ref-type="bibr"><sup>8</sup></xref> A number of recent controlled trials demonstrate efficacy of telehealth interventions for adult mental health disorders; examples include social phobia,<xref rid="bib9" ref-type="bibr"><sup>9</sup></xref> depression,<xref rid="bib10" ref-type="bibr"><sup>10</sup></xref> and OCD.<xref rid="bib11 bib12" ref-type="bibr"><sup>11,12</sup></xref> Increasingly, there is evidence of successful piloting telehealth interventions for childhood disorders, including a pilot study of webcam-delivered CBT&#x000a0;for adolescent OCD,<xref rid="bib13" ref-type="bibr"><sup>13</sup></xref> tic disorders,<xref rid="bib14" ref-type="bibr"><sup>14</sup></xref> and depression.<xref rid="bib15" ref-type="bibr"><sup>15</sup></xref> Telehealth treatment typically entails the same components as conventional face-to-face CBT but is simply delivered remotely, via a device.</p><p>Within the variety of telehealth methods available, telephone CBT (TCBT) has some important advantages for service providers and users, including relative ease of administration.<xref rid="bib16" ref-type="bibr"><sup>16</sup></xref> There is no need for hi-technology equipment, as most clinics have access to telephones and telephone ports, and many service users have a telephone or access to one. For these reasons, plus evidence suggesting that relatively few adolescents with OCD are able to access CBT<xref rid="bib17" ref-type="bibr"><sup>17</sup></xref> despite it being the recommended treatment,<xref rid="bib18" ref-type="bibr"><sup>18</sup></xref> TCBT was piloted for success and feasibility with adolescents with OCD in a London-based specialist clinic.<xref rid="bib19" ref-type="bibr"><sup>19</sup></xref> Results indicated that TCBT could successfully reduce symptoms of OCD and was regarded positively by service users.</p><p>The aim of the present study was to determine whether TCBT was as effective as face-to-face CBT for adolescents with OCD. As face-to-face CBT for OCD is a well-established treatment,<xref rid="bib5" ref-type="bibr"><sup>5</sup></xref> it is appropriate to use it as a benchmark against which to compare TCBT and to demonstrate non-inferiority. It was hypothesized that:<list list-type="simple"><list-item id="u0010"><label>&#x02022;</label><p>TCBT would not be inferior to traditional face-to-face CBT in reducing OCD symptoms as measured by the Children&#x02019;s Yale&#x02013;Brown Obsessive-Compulsive Scale (CY-BOCS).</p></list-item><list-item id="u0015"><label>&#x02022;</label><p>TCBT would not be inferior on secondary outcome measures of depressive symptoms, self-report, and parent-report of adolescent OCD symptoms, overall psychological health, global functioning, and parental mental health symptoms.</p></list-item><list-item id="u0020"><label>&#x02022;</label><p>The changes observed at the end of the treatment period would be maintained over a 12-month follow-up period.</p></list-item></list></p><sec sec-type="methods" id="sec1"><title>Method</title><sec id="sec1.1"><title>Recruitment and Inclusion Criteria</title><p>Participants were recruited by referral from primary care general practitioners and from mental health professionals within secondary and tertiary care settings within the National Health Service (NHS) to a specialist OCD clinic between 2008 and 2011. Information about the study was conveyed by word of mouth, letters to referring agencies, advertisements published on Web pages of national OCD charities within the UK, and by a research support organisation within the NHS (the Mental Health Research Network). The study protocol was approved by the Joint South London and Maudsley/Institute of Psychiatry Research Ethics Committee (08/H0807/12). Written informed consent was obtained from all parents and participants more than 16 years of age, and informed assent from participants less than 16 years of age, after&#x000a0;a detailed description of the study had been given.&#x000a0;The trial was registered on the International Standard Randomized Controlled Trial Number Register (ISRCTN27070832).</p><p>Inclusion criteria were as follows: having primary OCD according to <italic>DSM-IV</italic> criteria; having a CY-BOCS score of 16 or greater, indicating moderate to severe impairment; being between the ages of 11 and 18 years; being medication-free or on a stable dose of medication for a period of 12 weeks or more; having no suicidal intent, drug or alcohol abuse, or psychotic symptoms; having no learning disability or pervasive developmental disability; needing and wanting CBT, and agreeable to randomisation; and being agreeable to parental involvement in treatment. Exclusion criteria were the following: current diagnosis of psychosis or current alcohol or substance abuse/dependence; English comprehension too poor to engage in treatment; severe disabling neurological disorder; diagnosed global learning disability or pervasive developmental delay; and characteristics interfering with completion of treatment within trial (e.g., a life-threatening or unstable medical illness).</p></sec><sec id="sec1.2"><title>Measures</title><sec id="sec1.2.1"><title>Primary Outcome Measure</title><p>The primary outcome measure was the clinician-administrated CY-BOCS,<xref rid="bib20" ref-type="bibr"><sup>20</sup></xref> which was administered by a blinded rater at all time points.</p></sec><sec id="sec1.2.2"><title>Secondary Outcome Measures</title><p>The Children&#x02019;s Obsessional Compulsive Inventory&#x02013;Revised (ChOCI-R)<xref rid="bib21" ref-type="bibr"><sup>21</sup></xref> includes child- and parent-rated versions and is aimed at capturing subjective measures of OCD symptom severity and impairment.</p><p>The Beck Depression Inventory for Youth (BDI-Y)<xref rid="bib22" ref-type="bibr"><sup>22</sup></xref> assesses symptoms of depression in adolescents. Psychometric properties are sound.<xref rid="bib23" ref-type="bibr"><sup>23</sup></xref></p><p>The Strengths and Difficulties Questionnaire (SDQ)<xref rid="bib24" ref-type="bibr"><sup>24</sup></xref> assesses child mental health symptoms more broadly. We used the total score to provide a measure of general psychological functioning from both a child-rated and parent-rated perspective.</p><p>Parental mental health was assessed using the total score of the 42-item version of the Depression, Anxiety and Stress Scales (DASS).<xref rid="bib25" ref-type="bibr"><sup>25</sup></xref> The DASS has demonstrated strong psychometric properties in both clinical and community samples.<xref rid="bib26" ref-type="bibr"><sup>26</sup></xref></p></sec><sec id="sec1.2.3"><title>Diagnostic Assessment, Global Functioning, and Improvement</title><p>Blinded raters completed all diagnostic assessments and ratings of global functioning and improvement. Psychiatric diagnoses were established using the Anxiety Disorders Interview Schedule for Children (ADIS-IV-C/P).<xref rid="bib27" ref-type="bibr"><sup>27</sup></xref> The Children&#x02019;s Global Impression Scale (CGAS)<xref rid="bib28" ref-type="bibr"><sup>28</sup></xref> is a numeric scale ranging from 1 (needs constant supervision: 24-hour care) to 100 (superior functioning in all areas) and was used to rate the participant&#x02019;s overall general functioning. The Clinical Global Impression&#x02013;Improvement (CGI-I) rating scale<xref rid="bib29" ref-type="bibr"><sup>29</sup></xref> assessed how much the participant&#x02019;s symptoms had improved or worsened relative to baseline. Participants were rated on a 7-point scale ranging from 1 (very much improved) to 7 (very much worse).</p></sec><sec id="sec1.2.4"><title>Assessment of Treatment Credibility, Expectancy, and Satisfaction With Treatment Received</title><p>A treatment credibility and expectancy scale (modified from the measure presented by Devilly and Borkovec<xref rid="bib30" ref-type="bibr"><sup>30</sup></xref> to reflect use by adolescents with OCD) was used at 2 time points to determine whether participants and their parents viewed the treatments as equally credible. A treatment satisfaction questionnaire was developed to assess participant and parent satisfaction with the intervention; this was given to families posttreatment. Participant and parent satisfaction was also assessed using a qualitative methodology, which is reported separately (Lang <italic>et&#x000a0;al</italic>., in preparation, 2014).</p></sec></sec><sec id="sec1.3"><title>Procedure</title><p>Once referral to the specialist clinic was received, young persons and parents were asked to complete the ChOCI, SDQ, BDI (youth only), and the DASS (parents only). A face-to-face assessment was arranged, potential participants completed the CY-BOCS, and a clinical interview with parents was used by experienced psychiatrists/clinical psychologists to establish whether inclusion criteria were met. The study was offered, and information was provided. Families were contacted by telephone 1 week later, and if they were agreeable to the study, a second clinic appointment was arranged approximately 8 weeks after the initial meeting. At this&#x000a0;appointment, participants and their parents completed the ADIS-IV-C/P and the CY-BOCS in structured interviews, and self- and parent-report measures were completed again. Families were included in the study if participants remained symptomatic and full inclusion criteria were met. Randomization occurred at this time. After randomization, an appointment was made with the treating therapist, and treatment sessions commenced the following week. All treating therapists were experienced clinical psychologists, and all blinded raters completing assessments were either assistant psychologists or clinical psychologists, all of whom had specialist training and experience in assessing and treating childhood OCD.</p></sec><sec id="sec1.4"><title>Randomization and Assessment Points</title><p>Participants were randomly allocated to CBT or TCBT in a 1:1 ratio using a computer-generated randomization sequence, prepared before the study commenced, to which only the principal investigator (C.T.) had access. No other study personnel had access to the allocation; the allocation sequence was kept separate from all trial materials and personnel. Trial enrollment occurred at the time of the second assessment. The integrity of the randomization table was maintained and allocation concealment was ensured, with allocation provided only to treating therapists and allocated participants. There were no instances of delayed or prevented enrollment. There were no restrictions or matching.</p><p>A repeated-measures design was used, and assessments were conducted immediately before treatment (i.e., baseline), mid-treatment (i.e., session 7), immediately after treatment (i.e., posttreatment), and at follow-up points scheduled at 3 months, 6 months, and 12 months posttreatment. At each time point (except session 7), participants completed the CY-BOCS, ChOCI, SDQ, and BDI-Y, and parents completed the ChOCI, SDQ and DASS. At session 7, all participants in both groups were invited to the clinic for a blinded face-to-face CY-BOCS assessment; the results of this assessment were fed back to treating therapists to assist in planning future sessions. Treatment credibility and expectancy and a measure of therapeutic alliance were completed by participants and parents after session 2 and session&#x000a0;7.</p></sec><sec id="sec1.5"><title>Masking Procedures</title><p>To ensure that blindness was maintained, treating therapists and participants/parents were instructed not to discuss the treatment that they had received with the blinded assessors, and reminder cards were placed in the interview rooms. After completing the assessments, blinded raters noted whether blindness had been broken (for example, if the patient had inadvertently revealed his/her treatment group) and, if not, made a guess regarding the patient&#x02019;s group allocation.<xref rid="bib31" ref-type="bibr"><sup>31</sup></xref> A research assistant managed the allocation of blinded assessors and monitored blindness rating forms. Where blindness was inadvertently broken, outcome assessors were changed.</p></sec><sec id="sec1.6"><title>Monitoring of Treatment Integrity</title><p>Treatment integrity was ensured in 3 ways. First, a detailed treatment manual was used (Turner, 2006, unpublished), and, regardless of condition, participants received a workbook with clinical information and monitoring sheets. Second, all treating therapists received supervision by more senior clinical psychologists who were specialists in CBT for OCD. Finally, therapists were asked to audio-record all sessions (whenever possible) and to complete an integrity-to-protocol rating form developed for this study. A random sample of 225&#x000a0;recorded sessions (25%) were then audited and independently rated for integrity to protocol by a doctorate-level trainee in clinical psychology. The rate of adherence to the manual was 94% as measured by therapist report and was 93% as measured by independent audit. This is considered a high rate of treatment fidelity.<xref rid="bib32" ref-type="bibr"><sup>32</sup></xref> There were no differences in adherence ratings between conditions.</p></sec><sec id="sec1.7"><title>Treatment</title><p>Treatment consisted of 14 sessions of CBT delivered by&#x000a0;6 experienced clinical psychologists. Treatment was&#x000a0;identical within conditions except that participants randomized to TCBT received all treatment sessions via telephone. Sessions 1 and 2 consisted of psychoeducation, sessions 3 to 12 consisted of gradual exposure with response prevention (E/RP) and incorporated various cognitive strategies as appropriate, and sessions 13 and 14 consisted of relapse prevention and ongoing symptom management (if required). The treatment protocol incorporated 10 minutes of parental discussion at the end of each treatment session. Homework E/RP tasks were assigned between sessions, and participants were encouraged to complete daily E/RP. The treatment protocol has been validated in previous trials.<xref rid="bib19 bib33" ref-type="bibr"><sup>19,33</sup></xref> All 14 sessions were required to be completed within 17 weeks, allowing accommodation for illness, missed appointments, and holidays.</p></sec><sec id="sec1.8"><title>Power Analysis</title><p>A noninferiority margin of 5 points on the CY-BOCS was selected as the acceptable mean difference between conditions, based on clinical judgment and the adult trial of TCBT conducted by Lovell <italic>et&#x000a0;al.</italic><xref rid="bib11" ref-type="bibr"><sup>11</sup></xref> We estimated that with a sample size of 33 in each condition, a 2-group 0.05 1-sided test would have 80% power to reject the null hypothesis that TCBT is inferior to CBT (i.e., the difference in means is 5.0 or farther from 0 in the same direction) in favor of the alternative hypothesis that TCBT is not inferior, assuming that the expected difference in means is 0.0 and the common standard deviation is 8.0. To allow for drop-outs, we sought to recruit 72 participants (n&#x000a0;= 36 in each condition).</p><sec id="sec2.1"><title>Statistical Analysis</title><p>Little&#x02019;s Missing Completely at Random (MCAR) test was used to establish that missing data was&#x000a0;missing at random. Missing values on all outcome measures for all follow-up occasions were imputed via Multiple Imputation using Chained Equations (MICE) in Stata 11, with the ice command.<xref rid="bib34" ref-type="bibr"><sup>34</sup></xref> Ten imputed data sets were created for the CY-BOCS, and up to 100 imputed data sets were created for secondary outcome measures depending on the amount of missing data. The missing data at each occasion were imputed on the basis of observed values of each measure at all other time points. Because many of the measures were non-normally distributed, missing values were imputed through predictive mean matching,<xref rid="bib35" ref-type="bibr"><sup>35</sup></xref> which replaces missing values with observed values of similar cases. This avoids the potential for imputed values, which fall outside the observed range of the variable.</p><p>Data on outcome measures at each time point&#x000a0;after baseline were modeled using linear regression techniques with treatment condition as the key covariate. All models were also estimated separately, excluding cases with imputed values of the outcome variable as suggested by von Hippel.<xref rid="bib36" ref-type="bibr"><sup>36</sup></xref> However, as this did not substantively alter any of the conclusions, the results reported here use the imputed outcome values.</p><p>Non-inferiority is established when the confidence interval for the difference between treatment conditions excludes a prespecified margin of inferiority, typically chosen to represent a clinically significant difference.<xref rid="bib37" ref-type="bibr"><sup>37</sup></xref> As noted above, the margin of inferiority for the primary outcome was set at 5 points on the CY-BOCS scale using a 95% confidence interval. TCBT would be deemed non-inferior to CBT if the upper limit of the 95% confidence interval for the difference between TCBT and CBT is less than 5, meaning that we are&#x000a0;95% confident that the &#x0201c;true&#x0201d; value of the difference is not worse than 5 points on the CY-BOCS scale. For secondary outcome measures, the margin of inferiority was set for each measure at a difference of 1 standard deviation from the CBT condition mean for each assessment&#x000a0;point. All primary and secondary outcomes are&#x000a0;reported using an intent-to-treat sample of N&#x000a0;= 72. Last available observation data were used to determine the number of participants who could be classified as responders (i.e., CY-BOCS reduction of 35% or more) or remitters (i.e., CY-BOCS&#x000a0;&#x02264;12).<xref rid="bib38" ref-type="bibr"><sup>38</sup></xref></p></sec></sec></sec><sec sec-type="results" id="sec3"><title>Results</title><sec id="sec3.1"><title>Participant Characteristics</title><p>Participants were 72 adolescents aged 11 through 18 years and their parents. All participants were&#x000a0;outpatients with a primary diagnosis of OCD. Eleven young persons (15%) had a first-degree relative diagnosed with OCD. A total of 21 adolescents (29%) had received a previous trial of&#x000a0;CBT for OCD. Comorbid diagnoses included another anxiety disorder (n&#x000a0;=&#x000a0;39, 54.16%), depression or dysthymia (n&#x000a0;=&#x000a0;7, 9.7%), a&#x000a0;tic disorder&#x000a0;or Tourette syndrome (n&#x000a0;= 6, 8.3%), attention-deficit/hyperactivity disorder (ADHD; n&#x000a0;=&#x000a0;1, 1.4%), oppositional-defiant disorder (ODD; n&#x000a0;= 1, 1.4%), body dysmorphic disorder (BDD; n&#x000a0;= 1, 1.4%), and an eating disorder (n&#x000a0;= 1, 1.5%). <xref rid="tbl1" ref-type="table">Table&#x000a0;1</xref> presents additional demographic information and pretreatment clinical information;&#x000a0;there were no significant differences between groups. Participants in each condition received on&#x000a0;average 12 of the 14 CBT sessions offered.</p></sec><sec id="sec3.2"><title>Attrition</title><p><xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref> shows the participant flow throughout the trial.</p></sec><sec id="sec3.3"><title>Primary Outcome</title><p><xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref> presents the 95% confidence interval for the CY-BOCS mean difference between CBT and TCBT groups, and <xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref> presents the mean scores (with standard error) for both conditions across time. For all assessment points through to the 6-month follow-up, the difference between conditions was nonsignificant, and the 95% confidence interval lay below the 5-point difference margin, indicating that TCBT was not inferior to CBT. For the 12-month follow-up point, the 95% confidence interval included the margin of difference, and, based on the guidance provided by Piaggio <italic>et&#x000a0;al.</italic><xref rid="bib39" ref-type="bibr"><sup>39</sup></xref> for the Consolidated Standards of Reporting Trials (CONSORT) group, we conclude that the difference was nonsignificant; however, non-inferiority of TCBT could not conclusively be demonstrated at this time point.</p><p>As shown in <xref rid="tbl2" ref-type="table">Table&#x000a0;2</xref>, there were no group differences in the proportion of the sample who could be defined as treatment responders (defined as participants with a&#x000a0;&#x02265;35% reduction on the CY-BOCS) and remitters (defined as participants with CY-BOCS scores&#x000a0;&#x02264;12).</p></sec><sec id="sec3.4"><title>Secondary Outcomes</title><p><xref rid="appsec1" ref-type="sec">Table&#x000a0;S1</xref> (available online) presents the means, standard deviations, and 95% confidence interval data for all outcome measures. Based on the predetermined criteria of 1 standard deviation difference between the groups, analysis shows that the upper bound of the confidence intervals falls within the non-inferiority margin, confirming the non-inferiority hypothesis on all measures. For the CGAS, because higher scores reflect a greater level of overall functioning, the lower-bound confidence interval is the critical value, again confirming non-inferiority.</p></sec><sec id="sec3.5"><title>Clinician-Administrated Measure of Global Improvement and Functioning</title><p>There were no group differences in clinician-rated global functioning using the CGAS with non-inferiority of TCBT demonstrated, and no group differences with regard to global improvement using the CGI-I scale. Participants in both conditions improved over the course of the study, and improvements were maintained over the follow-up period (<xref rid="appsec1" ref-type="sec">Table&#x000a0;S1</xref>, available online).</p></sec><sec id="sec3.6"><title>Treatment Credibility and Expectancy</title><p>Credibility ratings were provided at the end of session 2. There were no significant differences in treatment credibility ratings provided by adolescents in the TCBT group (mean&#x000a0;= 23.26, SD&#x000a0;= 5.62) compared with those in the face-to-face group (mean&#x000a0;= 22.12, SD&#x000a0;= 4.73); t<sub>41</sub>&#x000a0;= 0.48, <italic>p</italic>&#x000a0;= .31. Similarly, there were no significant differences in credibility ratings provided by parents in the TCBT group (mean&#x000a0;= 23.61, SD&#x000a0;= 4.64) compared with those in the face-to-face group (mean&#x000a0;= 23.08, SD&#x000a0;= 5.41); t<sub>39</sub>&#x000a0;= 0.74, <italic>p</italic>&#x000a0;= .96.</p></sec><sec id="sec3.7"><title>Satisfaction With Treatment Received</title><p>Adolescents reported high levels of satisfaction, with 94.4% of youth reporting satisfaction with the help received, and no significant differences between groups (TCBT&#x000a0;= 96.3%, CBT&#x000a0;= 92.6%, &#x003c7;<sup>2</sup>[1, n&#x000a0;= 54]&#x000a0;= 0.35, <italic>p</italic>&#x000a0;= .552). The majority of adolescents (59.3%) reported that they were very happy with the treatment condition to which they were allocated. There was a significant difference between groups, with 77.8% of adolescents in the TCBT condition being very happy with their group allocation compared to 40.7% of adolescents in the CBT condition: &#x003c7;<sup>2</sup>(3, n&#x000a0;= 54)&#x000a0;= 8.89, <italic>p</italic>&#x000a0;= .031. Parents similarly reported high levels of&#x000a0;satisfaction, with no significant difference between treatment groups (TCBT&#x000a0;= 93.1%, CBT&#x000a0;= 88.9%, &#x003c7;<sup>2</sup>[3, n&#x000a0;= 56]&#x000a0;= 2.11, <italic>p</italic>&#x000a0;= .349).</p></sec><sec id="sec3.8"><title>Assessment of Blinding</title><p>Treatment condition was inadvertently revealed to blinded assessors in a small number of cases at each time point as follows: 2 patients at session 7; 3 patients at session 14; 1 patient at 3-month follow-up; 2 patients at 6-month follow-up; and 4 patients at 12-month follow-up. Excluding those, the blind raters&#x02019; guesses regarding treatment condition were no better than chance at session 7 (&#x003ba;&#x000a0;= 0.259, <italic>p</italic>&#x000a0;= .061), session 14 (&#x003ba;&#x000a0;=&#x000a0;&#x02212;0.003, <italic>p</italic>&#x000a0;= .984), 3-month follow-up (&#x003ba;= 0.005, <italic>p</italic>&#x000a0;= .967), 6-month follow-up (&#x003ba;&#x000a0;=&#x000a0;&#x02212;0.164, <italic>p</italic>&#x000a0;= .227), or 12-month follow-up (&#x003ba;&#x000a0;=&#x000a0;&#x02212;0.064, <italic>p</italic>&#x000a0;= .654).</p></sec></sec><sec sec-type="discussion" id="sec4"><title>Discussion</title><p>This study demonstrates that CBT for child and adolescent OCD delivered by telephone is not inferior in efficacy to the traditional method of clinic-based, face-to-face CBT. Blinded assessor ratings of OCD symptom severity demonstrated non-inferiority of TCBT from posttreatment through to 6-month follow-up. The results have significant potential to increase the accessibility of CBT for adolescents with OCD.</p><p>At 12-month follow-up, although the confidence intervals for the mean CY-BOCS score in the TCBT group fell outside the non-inferiority margin, no significant difference was observed between the conditions with respect to clinician-rated OCD symptoms, and importantly, according to child- and parent-reported OCD symptoms, TCBT was non-inferior to face-to-face CBT at all follow-up points. Similarly, non-inferiority was established at all time points for all other secondary outcome measures including child depressive symptoms, child global functioning, parental accommodation of OCD symptoms, and parental psychopathology.</p><p>Participant and parent responses to the telephone condition were positive. Adherence rates for both conditions were high, and participants and parents from both conditions reported high levels of satisfaction with the treatment received. Of note, a small number of families declined to participate in the study, as they did not want to be allocated to the TCBT condition (n&#x000a0;= 8). Conversely, there was a small number of families (n&#x000a0;= 3) who declined participation because they did not want to be allocated to the CBT condition, and the reason given was that the travel to the clinic was a deterrent. Interestingly, there was a significant difference between groups with regard to the number of young persons who reported satisfaction with their allocated condition, and a greater number of young persons reported being satisfied with the TCBT condition. Participants and parents within each condition reported equivalent levels of alliance/engagement with their treating therapist, and both conditions were perceived as credible.</p><p>Given that a non-inferiority design was used, it is important to consider whether face-to-face CBT was as effective as in previous trials. We found that face-to-face CBT was associated with a 51% reduction in OCD symptom severity over the acute phase of treatment and a 67% reduction from pretreatment to 12-month follow-up, which is commensurate with findings from previous controlled trials.<xref rid="bib40" ref-type="bibr"><sup>40</sup></xref> Furthermore, at posttreatment,&#x000a0;around 90% were classified as treatment responders and 61% as remitters, rates that are&#x000a0;consistent with or better than previous studies.<xref rid="bib33 bib41" ref-type="bibr"><sup>33,41</sup></xref> Face-to-face CBT in the current study can therefore be considered to be an appropriate benchmark.</p><p>The current findings suggest that TCBT has promise as a mode of treatment delivery and supports the general move toward integrating telehealth into mental health services.<xref rid="bib42" ref-type="bibr"><sup>42</sup></xref> TCBT has the potential to extend the availability of CBT to remote areas and/or regions with workforce shortages, thereby reducing geographical inequalities in the availability of CBT.<xref rid="bib43" ref-type="bibr"><sup>43</sup></xref> More generally, TCBT may be preferred to traditional face-to-face CBT by some families and services, because of its convenience and its potential to reduce demands on resources (e.g., travel, clinic space). A previous trial conducted among adults with OCD found that TCBT sessions were overall 50% shorter than face-to-face sessions, yet the 2 treatments were associated with equivalent clinical outcomes, suggesting a possible economic benefit of TCBT.<xref rid="bib11" ref-type="bibr"><sup>11</sup></xref> Further research is needed to establish whether TCBT may be more cost-effective than face-to-face CBT in pediatric OCD.</p><p>There are several strengths to this study, including the following: conformity to CONSORT guidelines for non-inferiority trials; adequate power to test the hypotheses; the inclusion of participants/parents who were seeking help through the UK NHS; inclusion/exclusion criteria designed to maximize generalizability; good retention (i.e., low attrition) rates; use of blinded outcome assessors; and use of a treatment protocol shown to be effective.<xref rid="bib19 bib33" ref-type="bibr"><sup>19,33</sup></xref> TCBT was therefore assessed for non-inferiority against a gold-standard treatment.</p><p>The findings should also be considered in the context of the study&#x02019;s limitations. First, the design did not include a no-treatment or placebo treatment control condition. Second, the noninferiority threshold of 5 could be considered as&#x000a0;high, and future studies may consider adopting a&#x000a0;more stringent threshold to allow for the potential detection of small between-group differences. Third, the study was conducted by experienced CBT therapists, and it cannot be assumed that the findings would necessarily translate to less experienced therapists or other service settings, although previous research has demonstrated that manualized CBT for pediatric OCD is transportable and effective when delivered in community settings by nonspecialist therapists.<xref rid="bib44" ref-type="bibr"><sup>44</sup></xref> Fourth, although every effort was made to complete an E/RP task within each session among sessions 3 through 12, there may have been some instances in which this was not&#x000a0;possible (e.g., because of participant reluctance or avoidance). In addition, we do not know whether homework compliance differs between CBT and TCBT. Finally, the current study included young persons aged 11 through 18 years, and although this is comparable to previous pediatric trials, the findings may not generalize to a younger population.</p><p>In summary, this is the first study to demonstrate that TCBT is as effective as face-to-face CBT for treatment of adolescent OCD, in both the short and medium term, and that it is associated with high levels of patient satisfaction. Further research is needed to explore the longer-term outcomes of TCBT as compared to face-to-face CBT and to examine potential predictors of outcome. Nevertheless, these findings suggest that telephone CBT could be a promising method for overcoming geographical barriers in accessing CBT.</p></sec></body><back><ref-list><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>Micali</surname><given-names>N.</given-names></name><name><surname>Heyman</surname><given-names>I.</given-names></name><name><surname>Perez</surname><given-names>M.</given-names></name></person-group><article-title>Long-term outcomes of obsessive-compulsive disorder: follow-up of 142 children and adolescents</article-title><source>Br J Psychiatry</source><volume>197</volume><year>2010</year><fpage>128</fpage><lpage>134</lpage><pub-id pub-id-type="pmid">20679265</pub-id></element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>Piacentini</surname><given-names>J.</given-names></name><name><surname>Bergman</surname><given-names>R.L.</given-names></name><name><surname>Keller</surname><given-names>M.</given-names></name><name><surname>McCracken</surname><given-names>J.</given-names></name></person-group><article-title>Functional impairment in children and adolescents with obsessive-compulsive disorder</article-title><source>J&#x000a0;Child Adolesc Psychopharmacol</source><volume>13</volume><issue>Suppl 1</issue><year>2010</year><fpage>61</fpage><lpage>69</lpage></element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name><surname>Heyman</surname><given-names>I.</given-names></name><name><surname>Fombonne</surname><given-names>E.</given-names></name><name><surname>Simmons</surname><given-names>H.</given-names></name><name><surname>Ford</surname><given-names>T.</given-names></name><name><surname>Meltzer</surname><given-names>H.</given-names></name><name><surname>Goodman</surname><given-names>R.</given-names></name></person-group><article-title>Prevalence of obsessive-compulsive disorder in the British Nationwide Survey of Child Mental Health</article-title><source>Br J Psychiatry</source><volume>179</volume><year>2001</year><fpage>324</fpage><lpage>329</lpage><pub-id pub-id-type="pmid">11581112</pub-id></element-citation></ref><ref id="bib4"><label>4</label><element-citation publication-type="book" id="sref4"><person-group person-group-type="author"><collab>National Collaborating Centre for Mental Health</collab></person-group><chapter-title>National Institute for Health and Clinical Excellence: Guidance. Obsessive-Compulsive Disorder: Core Interventions in the Treatment of Obsessive-Compulsive Disorder and Body Dysmorphic Disorder</chapter-title><year>2006</year><publisher-name>British Psychological Society and Royal College of Psychiatrists</publisher-name><publisher-loc>Leicester, UK</publisher-loc></element-citation></ref><ref id="bib5"><label>5</label><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name><surname>O'Kearney</surname><given-names>R.T.</given-names></name><name><surname>Anstey</surname><given-names>K.J.</given-names></name><name><surname>von Sanden</surname><given-names>C.</given-names></name></person-group><article-title>Behavioural and cognitive behavioural therapy for obsessive compulsive disorder in children and adolescents</article-title><source>Cochrane Database Syst Rev</source><year>2006</year><fpage>CD004856</fpage><pub-id pub-id-type="pmid">17054218</pub-id></element-citation></ref><ref id="bib6"><label>6</label><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name><surname>Nickelson</surname><given-names>D.W.</given-names></name></person-group><article-title>Telehealth and the evolving health care system: strategic opportunities for professional psychology</article-title><source>Prof Psychol</source><volume>29</volume><year>1998</year><fpage>527</fpage><lpage>535</lpage></element-citation></ref><ref id="bib7"><label>7</label><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>Bee</surname><given-names>P.E.</given-names></name><name><surname>Bower</surname><given-names>P.</given-names></name><name><surname>Lovell</surname><given-names>K.</given-names></name></person-group><article-title>Psychotherapy mediated by remote communication technologies: a meta-analytic review</article-title><source>BMC Psychiatry</source><volume>8</volume><year>2008</year><fpage>60</fpage><pub-id pub-id-type="pmid">18647396</pub-id></element-citation></ref><ref id="bib8"><label>8</label><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name><surname>Mataix-Cols</surname><given-names>D.</given-names></name><name><surname>Marks</surname><given-names>I.M.</given-names></name></person-group><article-title>Self-help with minimal therapist contact for obsessive-compulsive disorder: a review</article-title><source>Eur Psychiatry</source><volume>21</volume><year>2006</year><fpage>75</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">16360307</pub-id></element-citation></ref><ref id="bib9"><label>9</label><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Hedman</surname><given-names>E.</given-names></name><name><surname>Andersson</surname><given-names>G.</given-names></name><name><surname>Ljotsson</surname><given-names>B.</given-names></name></person-group><article-title>Internet-based cognitive behavior therapy vs. cognitive behavioral group therapy for social anxiety disorder: a randomized controlled non-inferiority trial</article-title><source>PLoS One</source><volume>6</volume><year>2011</year><fpage>e18001</fpage><pub-id pub-id-type="pmid">21483704</pub-id></element-citation></ref><ref id="bib10"><label>10</label><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name><surname>Mohr</surname><given-names>D.C.</given-names></name><name><surname>Vella</surname><given-names>L.</given-names></name><name><surname>Hart</surname><given-names>S.</given-names></name><name><surname>Heckman</surname><given-names>T.</given-names></name><name><surname>Simon</surname><given-names>G.</given-names></name></person-group><article-title>The effect of telephone-administered psychotherapy on symptoms of depression and attrition: a meta-analysis</article-title><source>Clin Psychol (New York)</source><volume>15</volume><year>2008</year><fpage>243</fpage><lpage>253</lpage><pub-id pub-id-type="pmid">21369344</pub-id></element-citation></ref><ref id="bib11"><label>11</label><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name><surname>Lovell</surname><given-names>K.</given-names></name><name><surname>Cox</surname><given-names>D.</given-names></name><name><surname>Haddock</surname><given-names>G.</given-names></name></person-group><article-title>Telephone administered cognitive behaviour therapy for treatment of obsessive compulsive disorder: randomised controlled non-inferiority trial</article-title><source>BMJ</source><volume>333</volume><year>2006</year><fpage>883</fpage><pub-id pub-id-type="pmid">16935946</pub-id></element-citation></ref><ref id="bib12"><label>12</label><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name><surname>Andersson</surname><given-names>E.</given-names></name><name><surname>Enander</surname><given-names>J.</given-names></name><name><surname>Andren</surname><given-names>P.</given-names></name></person-group><article-title>Internet-based cognitive behaviour therapy for obsessive-compulsive disorder: a randomized controlled trial</article-title><source>Psychological medicine</source><volume>42</volume><year>2012</year><fpage>2193</fpage><lpage>2203</lpage><pub-id pub-id-type="pmid">22348650</pub-id></element-citation></ref><ref id="bib13"><label>13</label><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name><surname>Storch</surname><given-names>E.A.</given-names></name><name><surname>Caporino</surname><given-names>N.E.</given-names></name><name><surname>Morgan</surname><given-names>J.R.</given-names></name></person-group><article-title>Preliminary investigation of&#x000a0;web-camera delivered cognitive-behavioral therapy for youth with obsessive-compulsive disorder</article-title><source>Psychiatry Res</source><volume>189</volume><year>2011</year><fpage>407</fpage><lpage>412</lpage><pub-id pub-id-type="pmid">21684018</pub-id></element-citation></ref><ref id="bib14"><label>14</label><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name><surname>Himle</surname><given-names>M.B.</given-names></name><name><surname>Freitag</surname><given-names>M.</given-names></name><name><surname>Walther</surname><given-names>M.</given-names></name><name><surname>Franklin</surname><given-names>S.A.</given-names></name><name><surname>Ely</surname><given-names>L.</given-names></name><name><surname>Woods</surname><given-names>D.W.</given-names></name></person-group><article-title>A&#x000a0;randomized pilot trial comparing videoconference versus face-to-face delivery of behavior therapy for childhood tic disorders</article-title><source>Behav Res Ther</source><volume>50</volume><year>2012</year><fpage>565</fpage><lpage>570</lpage><pub-id pub-id-type="pmid">22743661</pub-id></element-citation></ref><ref id="bib15"><label>15</label><element-citation publication-type="journal" id="sref15"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>E.L.</given-names></name><name><surname>Barnard</surname><given-names>M.</given-names></name><name><surname>Cain</surname><given-names>S.</given-names></name></person-group><article-title>Treating childhood depression over videoconferencing</article-title><source>Telemed J e-Health</source><volume>9</volume><year>2003</year><fpage>49</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">12699607</pub-id></element-citation></ref><ref id="bib16"><label>16</label><element-citation publication-type="book" id="sref16"><person-group person-group-type="author"><name><surname>Lovell</surname><given-names>K.</given-names></name></person-group><chapter-title>Supporting low intensity interventions using the telephone</chapter-title><person-group person-group-type="editor"><name><surname>Bennett-Levy</surname><given-names>J.</given-names></name><name><surname>Richards</surname><given-names>D.</given-names></name><name><surname>Farrand</surname><given-names>P.</given-names></name><name><surname>Christensen</surname><given-names>H.</given-names></name><name><surname>Griffiths</surname><given-names>K.</given-names></name></person-group><source>Oxford Guide to Low Intensity CBT Interventions</source><year>2010</year><publisher-name>Oxford University Press</publisher-name><publisher-loc>Oxford, UK</publisher-loc></element-citation></ref><ref id="bib17"><label>17</label><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name><surname>Chowdhury</surname><given-names>U.</given-names></name><name><surname>Frampton</surname><given-names>I.</given-names></name><name><surname>Heyman</surname><given-names>I.</given-names></name></person-group><article-title>Clinical characteristics of young people referred to an obsessive compulsive disorder clinic in the United Kingdom</article-title><source>Clin Child Psychol Psychiatry</source><volume>9</volume><year>2004</year><fpage>395</fpage><lpage>401</lpage></element-citation></ref><ref id="bib18"><label>18</label><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name><surname>Geller</surname><given-names>D.A.</given-names></name><name><surname>March</surname><given-names>J.</given-names></name></person-group><article-title>Practice parameter for the assessment and treatment of children and adolescents with obsessive-compulsive disorder</article-title><source>J&#x000a0;Am Acad Child Adolesc Psychiatry</source><volume>51</volume><year>2012</year><fpage>98</fpage><lpage>113</lpage><pub-id pub-id-type="pmid">22176943</pub-id></element-citation></ref><ref id="bib19"><label>19</label><element-citation publication-type="journal" id="sref19"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>C.</given-names></name><name><surname>Heyman</surname><given-names>I.</given-names></name><name><surname>Futh</surname><given-names>A.</given-names></name><name><surname>Lovell</surname><given-names>K.</given-names></name></person-group><article-title>A&#x000a0;pilot study of telephone cognitive-behavioural therapy for obsessive-compulsive disorder in young people</article-title><source>Behav Cogn Psychother</source><volume>37</volume><year>2009</year><fpage>469</fpage><lpage>474</lpage><pub-id pub-id-type="pmid">19545482</pub-id></element-citation></ref><ref id="bib20"><label>20</label><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name><surname>Scahill</surname><given-names>L.</given-names></name><name><surname>Riddle</surname><given-names>M.A.</given-names></name><name><surname>McSwiggin-Hardin</surname><given-names>M.</given-names></name></person-group><article-title>Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity</article-title><source>J&#x000a0;Am Acad Child Adolesc Psychiatry</source><volume>36</volume><year>1997</year><fpage>844</fpage><lpage>852</lpage><pub-id pub-id-type="pmid">9183141</pub-id></element-citation></ref><ref id="bib21"><label>21</label><element-citation publication-type="journal" id="sref21"><person-group person-group-type="author"><name><surname>Shafran</surname><given-names>R.</given-names></name><name><surname>Frampton</surname><given-names>I.</given-names></name><name><surname>Heyman</surname><given-names>I.</given-names></name><name><surname>Reynolds</surname><given-names>M.</given-names></name><name><surname>Teachman</surname><given-names>B.</given-names></name><name><surname>Rachman</surname><given-names>S.</given-names></name></person-group><article-title>The preliminary development of a new self-report measure for OCD in young people</article-title><source>J&#x000a0;Adolesc</source><volume>26</volume><year>2003</year><fpage>137</fpage><lpage>142</lpage><pub-id pub-id-type="pmid">12550826</pub-id></element-citation></ref><ref id="bib22"><label>22</label><element-citation publication-type="book" id="sref22"><person-group person-group-type="author"><name><surname>Beck</surname><given-names>J.S.</given-names></name></person-group><chapter-title>Beck Youth Inventories</chapter-title><year>2001</year><publisher-name>Psychological Corporation</publisher-name><publisher-loc>San Antonio, TX</publisher-loc></element-citation></ref><ref id="bib23"><label>23</label><element-citation publication-type="journal" id="sref23"><person-group person-group-type="author"><name><surname>Stapleton</surname><given-names>L.M.</given-names></name><name><surname>Sander</surname><given-names>J.B.</given-names></name><name><surname>Stark</surname><given-names>K.D.</given-names></name></person-group><article-title>Psychometric properties of the Beck Depression Inventory for Youth in a sample of girls</article-title><source>Psychol Assess</source><volume>19</volume><year>2007</year><fpage>230</fpage><lpage>235</lpage><pub-id pub-id-type="pmid">17563204</pub-id></element-citation></ref><ref id="bib24"><label>24</label><element-citation publication-type="journal" id="sref24"><person-group person-group-type="author"><name><surname>Goodman</surname><given-names>R.</given-names></name></person-group><article-title>The Strengths and Difficulties Questionnaire: a research note</article-title><source>J&#x000a0;Child Psychol Psychiatry Allied Discipl</source><volume>38</volume><year>1997</year><fpage>581</fpage><lpage>586</lpage></element-citation></ref><ref id="bib25"><label>25</label><element-citation publication-type="journal" id="sref25"><person-group person-group-type="author"><name><surname>Lovibond</surname><given-names>P.F.</given-names></name><name><surname>Lovibond</surname><given-names>S.H.</given-names></name></person-group><article-title>The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories</article-title><source>Behav Res Therapy</source><volume>33</volume><year>1995</year><fpage>335</fpage><lpage>343</lpage></element-citation></ref><ref id="bib26"><label>26</label><element-citation publication-type="journal" id="sref26"><person-group person-group-type="author"><name><surname>Antony</surname><given-names>M.M.</given-names></name><name><surname>Bieling</surname><given-names>P.J.</given-names></name><name><surname>Cox</surname><given-names>B.J.</given-names></name><name><surname>Enns</surname><given-names>M.W.</given-names></name><name><surname>Swinson</surname><given-names>R.P.</given-names></name></person-group><article-title>Psychometric properties of the 42-item and 21-item versions of the Depression Anxiety Stress Scales in clinical groups and a community sample</article-title><source>Psychol Assess</source><volume>10</volume><year>1998</year><fpage>176</fpage><lpage>181</lpage></element-citation></ref><ref id="bib27"><label>27</label><element-citation publication-type="book" id="sref27"><person-group person-group-type="author"><name><surname>Silverman</surname><given-names>W.K.</given-names></name><name><surname>Albano</surname><given-names>A.M.</given-names></name></person-group><chapter-title>Anxiety Disorders Interview Schedule for DSM-IV: Parent Interview Schedule</chapter-title><volume>Vol. 1</volume><year>1996</year><publisher-name>Oxford University Press</publisher-name><publisher-loc>Oxford, UK</publisher-loc></element-citation></ref><ref id="bib28"><label>28</label><element-citation publication-type="journal" id="sref28"><person-group person-group-type="author"><name><surname>Shaffer</surname><given-names>D.</given-names></name><name><surname>Gould</surname><given-names>M.S.</given-names></name><name><surname>Brasic</surname><given-names>J.</given-names></name></person-group><article-title>A&#x000a0;Children's Global Assessment Scale (CGAS)</article-title><source>Arch Gen Psychiatry</source><volume>40</volume><year>1983</year><fpage>1228</fpage><lpage>1231</lpage><pub-id pub-id-type="pmid">6639293</pub-id></element-citation></ref><ref id="bib29"><label>29</label><element-citation publication-type="book" id="sref29"><person-group person-group-type="editor"><name><surname>Guy</surname><given-names>W.</given-names></name></person-group><source>ECDEU Assessment Manual for Psychopharmacology</source><year>1976</year><publisher-name>US Department of Health, Education, and Welfare Public Health Service Alcohol, Drug Abuse, and Mental Health Administration</publisher-name><publisher-loc>Rockville, MD</publisher-loc></element-citation></ref><ref id="bib30"><label>30</label><element-citation publication-type="journal" id="sref30"><person-group person-group-type="author"><name><surname>Devilly</surname><given-names>G.J.</given-names></name><name><surname>Borkovec</surname><given-names>T.D.</given-names></name></person-group><article-title>Psychometric properties of the credibility/expectancy questionnaire</article-title><source>J&#x000a0;Behav Ther Exp Psychiatry</source><volume>31</volume><year>2000</year><fpage>73</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">11132119</pub-id></element-citation></ref><ref id="bib31"><label>31</label><element-citation publication-type="journal" id="sref31"><person-group person-group-type="author"><name><surname>Ba&#x0015f;o&#x0011f;lu</surname><given-names>M.</given-names></name><name><surname>Marks</surname><given-names>I.</given-names></name><name><surname>Livanou</surname><given-names>M.</given-names></name><name><surname>Swinson</surname><given-names>R.</given-names></name></person-group><article-title>Double-blindness procedures, rater blindness, and ratings of outcome: observations from a controlled trial</article-title><source>Arch Gen Psychiatry</source><volume>54</volume><year>1997</year><fpage>744</fpage><lpage>748</lpage><pub-id pub-id-type="pmid">9283510</pub-id></element-citation></ref><ref id="bib32"><label>32</label><element-citation publication-type="journal" id="sref32"><person-group person-group-type="author"><name><surname>Gearing</surname><given-names>R.E.</given-names></name><name><surname>El-Bassel</surname><given-names>N.</given-names></name><name><surname>Ghesquiere</surname><given-names>A.</given-names></name><name><surname>Baldwin</surname><given-names>S.</given-names></name><name><surname>Gillies</surname><given-names>J.</given-names></name><name><surname>Ngeow</surname><given-names>E.</given-names></name></person-group><article-title>Major ingredients of fidelity: a review and scientific guide to improving quality of intervention research implementation</article-title><source>Clin Psychol Rev</source><volume>31</volume><year>2011</year><fpage>79</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">21130938</pub-id></element-citation></ref><ref id="bib33"><label>33</label><element-citation publication-type="journal" id="sref33"><person-group person-group-type="author"><name><surname>Mataix-Cols</surname><given-names>D.</given-names></name><name><surname>Turner</surname><given-names>C.</given-names></name><name><surname>Monzani</surname><given-names>B.</given-names></name></person-group><article-title>Cognitive-behavioural therapy with post-session D-cycloserine augmentation for paediatric obsessive-compulsive disorder: pilot randomised controlled trial</article-title><source>Br J Psychiatry</source><volume>204</volume><year>2014</year><fpage>77</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">24262813</pub-id></element-citation></ref><ref id="bib34"><label>34</label><element-citation publication-type="journal" id="sref34"><person-group person-group-type="author"><name><surname>Royston</surname><given-names>P.</given-names></name></person-group><article-title>Multiple imputation of missing values</article-title><source>Stata J</source><volume>4</volume><year>2004</year><fpage>227</fpage><lpage>241</lpage></element-citation></ref><ref id="bib35"><label>35</label><element-citation publication-type="journal" id="sref35"><person-group person-group-type="author"><name><surname>White</surname><given-names>I.R.</given-names></name><name><surname>Royston</surname><given-names>P.</given-names></name><name><surname>Wood</surname><given-names>A.M.</given-names></name></person-group><article-title>Multiple imputation using chained equations: issues and guidance for practice</article-title><source>Stat Med</source><volume>30</volume><year>2011</year><fpage>377</fpage><lpage>399</lpage><pub-id pub-id-type="pmid">21225900</pub-id></element-citation></ref><ref id="bib36"><label>36</label><element-citation publication-type="journal" id="sref36"><person-group person-group-type="author"><name><surname>von Hippel</surname><given-names>P.</given-names></name></person-group><article-title>Regression with missing Ys: an improved strategy for analyzing multiply imputed data</article-title><source>Sociol Methodol</source><volume>37</volume><year>2007</year><fpage>83</fpage><lpage>117</lpage></element-citation></ref><ref id="bib37"><label>37</label><element-citation publication-type="journal" id="sref37"><person-group person-group-type="author"><name><surname>Nutt</surname><given-names>D.</given-names></name><name><surname>Allgulander</surname><given-names>C.</given-names></name><name><surname>Lecrubier</surname><given-names>Y.</given-names></name><name><surname>Peters</surname><given-names>T.</given-names></name><name><surname>Wittchen</surname><given-names>U.</given-names></name></person-group><article-title>Establishing non-inferiority in treatment trials in psychiatry: guidelines from an Expert Consensus Meeting</article-title><source>J&#x000a0;Psychopharmacol (Oxford, England)</source><volume>22</volume><year>2008</year><fpage>409</fpage><lpage>416</lpage></element-citation></ref><ref id="bib38"><label>38</label><element-citation publication-type="journal" id="sref38"><person-group person-group-type="author"><name><surname>Farris</surname><given-names>S.G.</given-names></name><name><surname>McLean</surname><given-names>C.P.</given-names></name><name><surname>Van Meter</surname><given-names>P.E.</given-names></name><name><surname>Simpson</surname><given-names>H.B.</given-names></name><name><surname>Foa</surname><given-names>E.B.</given-names></name></person-group><article-title>Treatment response, symptom remission, and wellness in obsessive-compulsive disorder</article-title><source>J&#x000a0;Clin Psychiatry</source><volume>74</volume><year>2013</year><fpage>685</fpage><lpage>690</lpage><pub-id pub-id-type="pmid">23945445</pub-id></element-citation></ref><ref id="bib39"><label>39</label><element-citation publication-type="journal" id="sref39"><person-group person-group-type="author"><name><surname>Piaggio</surname><given-names>G.</given-names></name><name><surname>Elbourne</surname><given-names>D.R.</given-names></name><name><surname>Pocock</surname><given-names>S.J.</given-names></name><name><surname>Evans</surname><given-names>S.J.</given-names></name><name><surname>Altman</surname><given-names>D.G.</given-names></name></person-group><article-title>Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement</article-title><source>JAMA</source><volume>308</volume><year>2012</year><fpage>2594</fpage><lpage>2604</lpage><pub-id pub-id-type="pmid">23268518</pub-id></element-citation></ref><ref id="bib40"><label>40</label><element-citation publication-type="journal" id="sref40"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>H.J.</given-names></name><name><surname>Rees</surname><given-names>C.S.</given-names></name></person-group><article-title>Meta-analysis of randomized, controlled treatment trials for pediatric obsessive-compulsive disorder</article-title><source>J&#x000a0;Child Psychol Psychiatry Allied Discipl</source><volume>49</volume><year>2008</year><fpage>489</fpage><lpage>498</lpage></element-citation></ref><ref id="bib41"><label>41</label><element-citation publication-type="journal" id="sref41"><person-group person-group-type="author"><name><surname>Bolton</surname><given-names>D.</given-names></name><name><surname>Williams</surname><given-names>T.</given-names></name><name><surname>Perrin</surname><given-names>S.</given-names></name></person-group><article-title>Randomized controlled trial of full and brief cognitive-behaviour therapy and wait-list for paediatric obsessive-compulsive disorder</article-title><source>J&#x000a0;Child Psychol Psychiatry Allied Disciplines</source><volume>52</volume><year>2011</year><fpage>1269</fpage><lpage>1278</lpage></element-citation></ref><ref id="bib42"><label>42</label><element-citation publication-type="journal" id="sref42"><person-group person-group-type="author"><name><surname>Myers</surname><given-names>K.M.</given-names></name><name><surname>Valentine</surname><given-names>J.M.</given-names></name><name><surname>Melzer</surname><given-names>S.M.</given-names></name></person-group><article-title>Feasibility, acceptability, and sustainability of telepsychiatry for children and adolescents</article-title><source>Psychiatr Serv (Washington, DC)</source><volume>58</volume><year>2007</year><fpage>1493</fpage><lpage>1496</lpage></element-citation></ref><ref id="bib43"><label>43</label><element-citation publication-type="journal" id="sref43"><person-group person-group-type="author"><name><surname>Shapiro</surname><given-names>D.A.</given-names></name><name><surname>Cavanagh</surname><given-names>K.</given-names></name><name><surname>Lomas</surname><given-names>H.</given-names></name></person-group><article-title>Geographic inequity in the availability of cognitive behavioural therapy in England and Wales</article-title><source>Behav Cogn Psychother</source><volume>31</volume><year>2003</year><fpage>185</fpage><lpage>192</lpage></element-citation></ref><ref id="bib44"><label>44</label><element-citation publication-type="journal" id="sref44"><person-group person-group-type="author"><name><surname>Farrell</surname><given-names>L.J.</given-names></name><name><surname>Schlup</surname><given-names>B.</given-names></name><name><surname>Boschen</surname><given-names>M.J.</given-names></name></person-group><article-title>Cognitive-behavioral treatment of childhood obsessive-compulsive disorder in community-based clinical practice: clinical significance and benchmarking against efficacy</article-title><source>Behav Res Ther</source><volume>48</volume><year>2010</year><fpage>409</fpage><lpage>417</lpage><pub-id pub-id-type="pmid">20181328</pub-id></element-citation></ref></ref-list><sec id="appsec1" sec-type="supplementary-material"><title>Supplemental Material</title><p><table-wrap id="dtbl1" position="anchor"><label>Table&#x000a0;S1</label><caption><p>Means (Standard Deviations), Mean Differences, and 95% CIs for Secondary Measures of Outcome</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Variable</th><th colspan="2">CBT Mean (SD)</th><th colspan="2">TCBT Mean (SD)</th><th>Coefficient Mean Diff.</th><th>95% CI Lower&#x000a0;Bound</th><th>95% CI Upper&#x000a0;Bound</th></tr></thead><tbody><tr><td>CY-BOCS Obsessions</td><td/><td/><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;Baseline</td><td align="char">11.67</td><td align="char">(2.30)</td><td align="char">12.36</td><td align="char">(2.20)</td><td/><td/><td/></tr><tr><td>&#x000a0;Post-tx (T3)</td><td align="char">6.12</td><td align="char">(3.10)</td><td align="char">6.24</td><td align="char">(4.23)</td><td align="char">0.06</td><td align="char">&#x02212;1.76</td><td align="char">1.87</td></tr><tr><td>&#x000a0;3-mo FU (T4)</td><td align="char">6.12</td><td align="char">(3.40)</td><td align="char">6.70</td><td align="char">(4.40)</td><td align="char">0.38</td><td align="char">&#x02212;1.56</td><td align="char">2.31</td></tr><tr><td>&#x000a0;6-mo FU (T5)</td><td align="char">5.46</td><td align="char">(3.31)</td><td align="char">6.06</td><td align="char">(4.31)</td><td align="char">0.52</td><td align="char">&#x02212;1.34</td><td align="char">2.37</td></tr><tr><td>&#x000a0;12-mo FU (T6)</td><td align="char">4.00</td><td align="char">(3.84)</td><td align="char">5.71</td><td align="char">(4.69)</td><td align="char">1.60</td><td align="char">&#x02212;0.49</td><td align="char">3.70</td></tr><tr><td>CY-BOCS Compulsions</td><td/><td/><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;Baseline</td><td align="char">12.44</td><td align="char">(2.05)</td><td align="char">13.28</td><td align="char">(2.02)</td><td/><td/><td/></tr><tr><td>&#x000a0;Post-tx (T3)</td><td align="char">5.55</td><td align="char">(3.19)</td><td align="char">6.82</td><td align="char">(4.45)</td><td align="char">1.09</td><td align="char">&#x02212;0.80</td><td align="char">2.99</td></tr><tr><td>&#x000a0;3-mo FU (T4)</td><td align="char">6.04</td><td align="char">(3.43)</td><td align="char">6.64</td><td align="char">(4.43)</td><td align="char">0.54</td><td align="char">&#x02212;1.44</td><td align="char">2.51</td></tr><tr><td>&#x000a0;6-mo FU (T5)</td><td align="char">5.57</td><td align="char">(3.31)</td><td align="char">5.83</td><td align="char">(4.89)</td><td align="char">0.16</td><td align="char">&#x02212;1.87</td><td align="char">2.19</td></tr><tr><td>&#x000a0;12-mo FU (T6)</td><td align="char">4.39</td><td align="char">(3.80)</td><td align="char">5.53</td><td align="char">(4.75)</td><td align="char">1.41</td><td align="char">&#x02212;0.79</td><td align="char">3.60</td></tr><tr><td>CY-BOCS Total</td><td/><td/><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;Baseline</td><td align="char">24.11</td><td align="char">(4.02)</td><td align="char">25.64</td><td align="char">(3.86)</td><td/><td/><td/></tr><tr><td>&#x000a0;Post-tx (T3)</td><td align="char">11.72</td><td align="char">(6.06)</td><td align="char">12.99</td><td align="char">(8.56)</td><td align="char">1.06</td><td align="char">&#x02212;2.61</td><td align="char">4.73</td></tr><tr><td>&#x000a0;3-mo FU (T4)</td><td align="char">12.23</td><td align="char">(6.48)</td><td align="char">13.32</td><td align="char">(8.67)</td><td align="char">0.74</td><td align="char">&#x02212;3.06</td><td align="char">4.53</td></tr><tr><td>&#x000a0;6-mo FU (T5)</td><td align="char">10.91</td><td align="char">(6.07)</td><td align="char">11.90</td><td align="char">(9.10)</td><td align="char">0.35</td><td align="char">&#x02212;3.45</td><td align="char">4.14</td></tr><tr><td>&#x000a0;12-mo FU (T6)</td><td align="char">8.07</td><td align="char">(7.36)</td><td align="char">10.94</td><td align="char">(9.17)</td><td align="char">2.78</td><td align="char">&#x02212;1.38</td><td align="char">6.94</td></tr><tr><td>CHOCI-C Total</td><td/><td/><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;Baseline</td><td align="char">23.21</td><td align="char">(8.70)</td><td align="char">24.11</td><td align="char">(7.01)</td><td/><td/><td/></tr><tr><td>&#x000a0;Post-tx (T3)</td><td align="char">14.36</td><td align="char">(8.21)</td><td align="char">13.14</td><td align="char">(10.77)</td><td align="char">&#x02212;1.15</td><td align="char">&#x02212;5.96</td><td align="char">3.65</td></tr><tr><td>&#x000a0;3-mo FU (T4)</td><td align="char">13.85</td><td align="char">(8.74)</td><td align="char">14.09</td><td align="char">(10.05)</td><td align="char">&#x02212;0.65</td><td align="char">&#x02212;5.30</td><td align="char">3.99</td></tr><tr><td>&#x000a0;6-mo FU (T5)</td><td align="char">11.53</td><td align="char">(9.49)</td><td align="char">13.47</td><td align="char">(9.84)</td><td align="char">0.67</td><td align="char">&#x02212;4.20</td><td align="char">5.54</td></tr><tr><td>&#x000a0;12-mo FU (T6)</td><td align="char">11.95</td><td align="char">(9.84)</td><td align="char">13.16</td><td align="char">(10.97)</td><td align="char">0.23</td><td align="char">&#x02212;4.90</td><td align="char">5.36</td></tr><tr><td>CHOCI-P Total</td><td/><td/><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;Baseline</td><td align="char">22.65</td><td align="char">(8.81)</td><td align="char">24.53</td><td align="char">(9.12)</td><td/><td/><td/></tr><tr><td>&#x000a0;Post-tx (T3)</td><td align="char">12.26</td><td align="char">(9.45)</td><td align="char">12.77</td><td align="char">(11.87)</td><td align="char">&#x02212;0.24</td><td align="char">&#x02212;3.29</td><td align="char">2.81</td></tr><tr><td>&#x000a0;3-mo FU (T4)</td><td align="char">11.61</td><td align="char">(11.59)</td><td align="char">12.98</td><td align="char">(10.01)</td><td align="char">0.73</td><td align="char">&#x02212;2.65</td><td align="char">4.12</td></tr><tr><td>&#x000a0;6-mo FU (T5)</td><td align="char">11.64</td><td align="char">(10.83)</td><td align="char">13.06</td><td align="char">(9.08)</td><td align="char">0.78</td><td align="char">&#x02212;2.53</td><td align="char">4.08</td></tr><tr><td>&#x000a0;12-mo FU (T6)</td><td align="char">10.30</td><td align="char">(11.52)</td><td align="char">11.93</td><td align="char">(10.68)</td><td align="char">1.68</td><td align="char">&#x02212;1.63</td><td align="char">4.99</td></tr><tr><td>BDI-Y</td><td/><td/><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;Baseline</td><td align="char">14.44</td><td align="char">(8.77)</td><td align="char">14.58</td><td align="char">(8.73)</td><td/><td/><td/></tr><tr><td>&#x000a0;Post-tx (T3)</td><td align="char">10.98</td><td align="char">(10.16)</td><td align="char">11.08</td><td align="char">(11.28)</td><td align="char">0.11</td><td align="char">&#x02212;4.77</td><td align="char">4.99</td></tr><tr><td>&#x000a0;3-mo FU (T4)</td><td align="char">11.38</td><td align="char">(10.85)</td><td align="char">8.16</td><td align="char">(6.88)</td><td align="char">&#x02212;3.67</td><td align="char">&#x02212;8.29</td><td align="char">0.95</td></tr><tr><td>&#x000a0;6-mo FU (T5)</td><td align="char">10.04</td><td align="char">(9.38)</td><td align="char">6.55</td><td align="char">(5.02)</td><td align="char">&#x02212;3.81</td><td align="char">&#x02212;7.60</td><td align="char">0.30</td></tr><tr><td>&#x000a0;12-mo FU (T6)</td><td align="char">8.22</td><td>(6.30)</td><td align="char">6.89</td><td align="char">(6.95)</td><td align="char">&#x02212;1.71</td><td align="char">&#x02212;4.95</td><td align="char">1.52</td></tr><tr><td>DASS-M Total</td><td/><td/><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;Baseline</td><td align="char">17.68</td><td align="char">(18.63)</td><td align="char">15.53</td><td align="char">(14.04)</td><td/><td/><td/></tr><tr><td>&#x000a0;Post-tx (T3)</td><td align="char">13.55</td><td align="char">(19.95)</td><td align="char">14.58</td><td align="char">(16.44)</td><td align="char">2.19</td><td align="char">&#x02212;6.86</td><td align="char">11.24</td></tr><tr><td>&#x000a0;3-mo FU (T4)</td><td align="char">16.28</td><td align="char">(21.10)</td><td align="char">8.96</td><td align="char">(9.87)</td><td align="char">&#x02212;6.69</td><td align="char">&#x02212;14.85</td><td align="char">1.47</td></tr><tr><td>&#x000a0;6-mo FU (T5)</td><td align="char">13.20</td><td align="char">(13.08)</td><td align="char">13.55</td><td align="char">(14.27)</td><td align="char">0.83</td><td align="char">&#x02212;6.27</td><td align="char">7.92</td></tr><tr><td>&#x000a0;12-mo FU (T6)</td><td align="char">10.60</td><td align="char">(14.88)</td><td align="char">13.75</td><td align="char">(18.53)</td><td align="char">4.27</td><td align="char">&#x02212;3.59</td><td align="char">12.13</td></tr><tr><td>DASS-F Total</td><td/><td/><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;Baseline</td><td align="char">15.33</td><td align="char">(17.11)</td><td align="char">8.56</td><td align="char">(5.50)</td><td/><td/><td/></tr><tr><td>&#x000a0;Post-tx (T3)</td><td align="char">7.25</td><td align="char">(8.92)</td><td align="char">13.26</td><td align="char">(19.29)</td><td align="char">7.85</td><td align="char">&#x02212;3.66</td><td align="char">19.35</td></tr><tr><td>&#x000a0;3-mo FU (T4)</td><td align="char">16.33</td><td align="char">(18.50)</td><td align="char">9.50</td><td align="char">(12.11)</td><td align="char">&#x02212;5.79</td><td align="char">&#x02212;15.52</td><td align="char">3.95</td></tr><tr><td>&#x000a0;6-mo FU (T5)</td><td align="char">14.40</td><td align="char">(19.41)</td><td align="char">10.25</td><td align="char">(15.57)</td><td align="char">&#x02212;1.26</td><td align="char">&#x02212;10.11</td><td align="char">7.58</td></tr><tr><td>&#x000a0;12-mo FU (T6)</td><td align="char">12.79</td><td align="char">(11.34)</td><td align="char">6.18</td><td align="char">(5.78)</td><td align="char">&#x02212;5.04</td><td align="char">&#x02212;13.39</td><td align="char">3.31</td></tr><tr><td>SDQ-P Total</td><td/><td/><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;Baseline</td><td align="char">17.21</td><td align="char">(3.86)</td><td align="char">16.26</td><td align="char">(4.37)</td><td/><td/><td/></tr><tr><td>&#x000a0;Post-tx (T3)</td><td align="char">14.37</td><td align="char">(3.55)</td><td align="char">15.13</td><td align="char">(4.24)</td><td align="char">0.89</td><td align="char">&#x02212;1.06</td><td align="char">2.85</td></tr><tr><td>&#x000a0;3-mo FU (T4)</td><td align="char">13.89</td><td align="char">(4.72)</td><td align="char">14.24</td><td align="char">(4.04)</td><td align="char">0.52</td><td align="char">&#x02212;1.76</td><td align="char">2.8</td></tr><tr><td>&#x000a0;6-mo FU (T5)</td><td align="char">13.73</td><td align="char">(3.39)</td><td align="char">13.78</td><td align="char">(3.43)</td><td align="char">0.06</td><td align="char">&#x02212;1.92</td><td align="char">2.04</td></tr><tr><td>&#x000a0;12-mo FU (T6)</td><td align="char">13.84</td><td align="char">(4.60)</td><td align="char">13.29</td><td align="char">(3.74)</td><td align="char">&#x02212;0.34</td><td align="char">&#x02212;2.56</td><td align="char">1.89</td></tr><tr><td>SDQ-C Total</td><td/><td/><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;Baseline</td><td align="char">16.63</td><td align="char">(3.37)</td><td align="char">17.13</td><td align="char">(3.71)</td><td/><td/><td/></tr><tr><td>&#x000a0;Post-tx (T3)</td><td align="char">14.64</td><td align="char">(3.36)</td><td align="char">14.97</td><td align="char">(3.90)</td><td align="char">0.29</td><td align="char">&#x02212;1.56</td><td align="char">2.13</td></tr><tr><td>&#x000a0;3-mo FU (T4)</td><td align="char">14.08</td><td align="char">(3.20)</td><td align="char">15.08</td><td align="char">(3.91)</td><td align="char">0.87</td><td align="char">&#x02212;0.94</td><td align="char">2.70</td></tr><tr><td>&#x000a0;6-mo FU (T5)</td><td align="char">13.60</td><td align="char">(2.90)</td><td align="char">15.01</td><td align="char">(3.64)</td><td align="char">1.17</td><td align="char">&#x02212;0.44</td><td align="char">2.78</td></tr><tr><td>&#x000a0;12-mo FU (T6)</td><td align="char">13.64</td><td align="char">(3.07)</td><td align="char">14.48</td><td align="char">(3.59)</td><td align="char">0.83</td><td align="char">&#x02212;0.94</td><td align="char">2.60</td></tr><tr><td>CGAS</td><td/><td/><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;Baseline</td><td align="char">50.53</td><td align="char">(7.06)</td><td align="char">50.00</td><td align="char">(7.49)</td><td/><td/><td/></tr><tr><td>&#x000a0;Post-tx (T3)</td><td align="char">74.28</td><td align="char">(14.23)</td><td align="char">71.37</td><td align="char">(17.61)</td><td align="char">&#x02212;2.56</td><td align="char">&#x02212;10.18</td><td align="char">5.06</td></tr><tr><td>&#x000a0;3-mo FU (T4)</td><td align="char">72.10</td><td align="char">(15.01)</td><td align="char">70.74</td><td align="char">(17.26)</td><td align="char">0.31</td><td align="char">&#x02212;7.38</td><td align="char">8.00</td></tr><tr><td>&#x000a0;6-mo FU (T5)</td><td align="char">71.50</td><td align="char">(10.30)</td><td align="char">73.22</td><td align="char">(16.94)</td><td align="char">3.07</td><td align="char">&#x02212;4.02</td><td align="char">9.16</td></tr><tr><td>&#x000a0;12-mo FU (T6)</td><td align="char">76.92</td><td align="char">(15.02)</td><td align="char">74.25</td><td align="char">(14.06)</td><td align="char">&#x02212;2.17</td><td align="char">&#x02212;9.59</td><td align="char">5.25</td></tr><tr><td>CGI-I</td><td/><td/><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;Baseline</td><td align="char">4.12</td><td align="char">(0.59)</td><td align="char">4.10</td><td align="char">(0.33)</td><td align="char">&#x02212;0.02</td><td align="char">&#x02212;0.25</td><td align="char">0.21</td></tr><tr><td>&#x000a0;Post-tx (T3)</td><td align="char">1.84</td><td align="char">(0.67)</td><td align="char">1.98</td><td align="char">(1.09)</td><td align="char">0.13</td><td align="char">&#x02212;0.31</td><td align="char">0.58</td></tr><tr><td>&#x000a0;3-mo FU (T4)</td><td align="char">2.14</td><td align="char">(1.01)</td><td align="char">1.91</td><td align="char">(0.92)</td><td align="char">&#x02212;0.24</td><td align="char">&#x02212;0.75</td><td align="char">0.26</td></tr><tr><td>&#x000a0;6-mo FU (T5)</td><td align="char">1.97</td><td align="char">(0.91)</td><td align="char">1.87</td><td align="char">(1.09)</td><td align="char">&#x02212;0.11</td><td align="char">&#x02212;0.64</td><td align="char">0.42</td></tr><tr><td>&#x000a0;12-mo FU (T6)</td><td align="char">1.61</td><td align="char">(1.09)</td><td align="char">1.81</td><td align="char">(1.01)</td><td align="char">0.20</td><td align="char">&#x02212;0.45</td><td align="char">0.84</td></tr></tbody></table><table-wrap-foot><fn><p>Note: BDI-Y&#x000a0;= Beck Depression Inventory for Youth; CBT&#x000a0;= cognitive-behavioral therapy; CGAS&#x000a0;= Clinical Global Assessment Scale; CGI-I&#x000a0;= Clinical Global Impression Improvement Scale; CHOCI-C&#x000a0;= Children&#x02019;s Obsessional Compulsive Inventory Revised&#x02013;Child; CHOCI-P&#x000a0;= Children&#x02019;s Obsessional Compulsive Inventory Revised&#x02013;Parent; CY-BOCS&#x000a0;= Children&#x02019;s Yale&#x02013;Brown Obsessive Compulsive Scale; DASS-F&#x000a0;= Depression Anxiety Stress Scale&#x02013;Father; DASS-M&#x000a0;= Depression Anxiety Stress Scale&#x02013;Mother; FAS-F&#x000a0;= Family Accommodation Scale&#x02013;Father; FAS-M&#x000a0;= Family Accommodation Scale&#x02013;Mother; FU&#x000a0;= follow-up assessment; Post-tx&#x000a0;= posttreatment; SDQ-C&#x000a0;= Strengths and Difficulties Questionnaire&#x02013;Child Version; SDQ-P&#x000a0;= Strengths and Difficulties Questionnaire&#x02013;Parent Version; TCBT&#x000a0;= telephone cognitive-behavioral therapy.</p></fn></table-wrap-foot></table-wrap></p></sec><ack id="ack0010"><p>The authors thank the NHS Mental Health Research Network for assistance with recruitment of participants. The authors thank Chlo&#x000eb; Volz, CPsychol; Kristina Hilton, DPsy; Jacinda Cadman, MClinPsy; Holly Diamond, DPsy; Amy Shayle, DPsy; Amita Jassi, DPsy; and Caroline Stokes, DPsy, of the South London and Maudsley NHS Foundation Trust, for their contributions to this project. The authors also thank Erin Pownell, Queensland Certificate of Education, and Martin O&#x02019;Flaherty, BA (Hons), from the University of Queensland, for their assistance with the preparation of this article.</p></ack><fn-group><fn id="d32e445"><p>This research was funded by the National Institute for Health Research (NIHR) under its Research for Patients Benefit (RfPB) Programme (grant reference number PB-PG-0107-12333). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health.</p></fn><fn id="d32e448"><p>Martin O&#x02019;Flaherty, BA (Hons), of the University of Queensland, served as the statistical expert for this research.</p></fn><fn id="d32e451"><p>Disclosure: Dr.&#x000a0;Turner has received grant funding from the NIHR and The Maudsley Charity (UK). Dr.&#x000a0;Mataix-Cols has received salary support from the Karolinska Institutet, Sweden. He has received grant funding from the National Institute of Mental Health (UK), the Maudsley Charity (UK), and the Stockholm County Council (Avtal om L&#x000e4;karutbildning och Forskning [ALF] Project). Dr.&#x000a0;Krebs has received salary support from the NIHR Mental Health Biomedical Research Centre at the South London and Maudsley NHS Foundation Trust and Kings College London. She has received grant funding from the NIHR. Ms. Lang has received salary support from the NIHR Mental Health Biomedical Research Centre at the South London and Maudsley NHS Foundation Trust and Kings College London. Drs. Lovell, Byford, and Heyman report no biomedical financial interests or potential conflicts of interest.</p></fn></fn-group></back><floats-group><fig id="fig1"><label>Figure&#x000a0;1</label><caption><p>Consolidated Standards of Reporting Trials (CONSORT) diagram. Note: CBT&#x000a0;= cognitive-behavioral therapy; ITT&#x000a0;= intention to treat; TCBT&#x000a0;= telephone cognitive-behavioral therapy.</p></caption><graphic xlink:href="gr1"/></fig><fig id="fig2"><label>Figure&#x000a0;2</label><caption><p>Ninety-five percent CI for the difference in Children&#x02019;s Yale-Brown Obsessive Compulsive Scale (CY-BOCS) between telephone cognitive-behavioral therapy (TCBT) and cognitive-behavioral therapy (CBT) conditions.</p></caption><graphic xlink:href="gr2"/></fig><fig id="fig3"><label>Figure&#x000a0;3</label><caption><p>Total Children&#x02019;s Yale&#x02013;Brown Obsessive Compulsive Scale (CY-BOCS) mean scores (with standard error) for the cognitive-behavioral therapy (CBT) and telephone cognitive-behavioral therapy (TCBT) conditions. Note: M-FU&#x000a0;= months of follow-up; post-tx&#x000a0;= posttreatment.</p></caption><graphic xlink:href="gr3"/></fig><table-wrap id="tbl1" position="float"><label>Table&#x000a0;1</label><caption><p>Pretreatment Clinical and Demographic Variables for Participants With Each Condition</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Variable</th><th colspan="2">CBT (n&#x000a0;= 36)</th><th colspan="2">TCBT (n&#x000a0;= 36)</th></tr></thead><tbody><tr><td>Age, y</td><td align="char">14.50</td><td align="char">(2.19)</td><td align="char">14.19</td><td>(2.07)</td></tr><tr><td>Age at OCD Onset</td><td align="char">10.97</td><td align="char">(3.12)</td><td align="char">11.00</td><td>(3.61)</td></tr><tr><td>Female Gender, %</td><td align="char">47.2</td><td/><td align="char">44.4</td><td/></tr><tr><td>Male Gender, %</td><td align="char">52.8</td><td/><td align="char">55.6</td><td/></tr><tr><td>On stable SSRI Medication, %</td><td align="char">22.6</td><td/><td align="char">17.9</td><td/></tr><tr><td>Previous CBT Treatment, n (%)</td><td align="char">8</td><td align="char">(22.2)</td><td align="char">13</td><td>(36.1)</td></tr><tr><td>CY-BOCS Obsessions</td><td align="char">11.67</td><td align="char">(2.30)</td><td align="char">12.36</td><td>(2.20)</td></tr><tr><td>CY-BOCS Compulsions</td><td align="char">12.44</td><td align="char">(2.05)</td><td align="char">13.28</td><td>(2.02)</td></tr><tr><td>CY-BOCS Total</td><td align="char">24.11</td><td align="char">(4.02)</td><td align="char">25.64</td><td>(3.86)</td></tr><tr><td>CHOCI-C Total</td><td align="char">23.21</td><td align="char">(8.70)</td><td align="char">24.11</td><td>(7.01)</td></tr><tr><td>CHOCI-P Total</td><td align="char">22.65</td><td align="char">(8.81)</td><td align="char">24.53</td><td>(9.12)</td></tr><tr><td>BDI-Y</td><td align="char">14.44</td><td align="char">(8.77)</td><td align="char">14.58</td><td>(8.73)</td></tr><tr><td>FAS-M Total</td><td align="char">20.33</td><td align="char">(12.75)</td><td align="char">21.45</td><td>(11.32)</td></tr><tr><td>FAS-F Total</td><td align="char">13.36</td><td align="char">(7.48)</td><td align="char">13.18</td><td>(7.82)</td></tr><tr><td>DASS-M Total</td><td align="char">17.68</td><td align="char">(18.63)</td><td align="char">15.53</td><td>(14.04)</td></tr><tr><td>DASS-F Total</td><td align="char">15.33</td><td align="char">(17.11)</td><td align="char">8.56</td><td>(5.50)</td></tr><tr><td>SDQ-P Total</td><td align="char">17.21</td><td align="char">(3.86)</td><td align="char">16.26</td><td>(4.37)</td></tr><tr><td>SDQ-C Total</td><td align="char">16.63</td><td align="char">(3.37)</td><td align="char">17.13</td><td>(3.71)</td></tr><tr><td>CGAS</td><td align="char">50.53</td><td align="char">(7.06)</td><td align="char">50.00</td><td>(7.49)</td></tr></tbody></table><table-wrap-foot><fn><p>Note: Values represent mean and SD unless otherwise specified. BDI-Y&#x000a0;= Beck Depression Inventory for Youth; CBT&#x000a0;= cognitive-behavioral therapy; CGAS&#x000a0;= Clinical Global Assessment Scale; CHOCI-C&#x000a0;= Children&#x02019;s Obsessional Compulsive Inventory Revised&#x02013;Child; CHOCI-P&#x000a0;= Children&#x02019;s Obsessional Compulsive Inventory Revised&#x02013;Parent; CY-BOCS&#x000a0;= Children&#x02019;s Yale&#x02013;Brown Obsessive Compulsive Scale; DASS-F&#x000a0;= Depression Anxiety Stress Scale&#x02013;Father; DASS-M&#x000a0;= Depression Anxiety Stress Scale&#x02013;Mother; FAS-F&#x000a0;= Family Accommodation Scale&#x02013;Father; FAS-M&#x000a0;= Family Accommodation Scale&#x02013;Mother; OCD&#x000a0;= obsessive-compulsive disorder; SDQ-C&#x000a0;= Strengths and Difficulties Questionnaire&#x02013;Child Version; SDQ-P&#x000a0;= Strengths and Difficulties Questionnaire&#x02013;Parent Version; SSRI&#x000a0;= selective serotonin reuptake inhibitor; TCBT&#x000a0;= telephone cognitive-behavioral therapy.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl2" position="float"><label>Table&#x000a0;2</label><caption><p>Cognitive-Behavioral Therapy (CBT) Sessions, and Percentage of Sample Classified as CBT Responders<xref rid="tbl2fna" ref-type="table-fn">a</xref> and Remitters,<xref rid="tbl2fnb" ref-type="table-fn">b</xref> Based on Last Available Observation</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>CBT</th><th>TCBT</th><th><italic>&#x003c7;</italic><sup><italic>2</italic></sup></th><th><italic>Df</italic></th><th><italic>P</italic></th></tr></thead><tbody><tr><td>Responders, %</td><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;Posttreatment</td><td align="char">90.6</td><td align="char">87.5</td><td align="char">0.160</td><td align="char">1</td><td align="char">.689</td></tr><tr><td>&#x000a0;3-mo follow-up</td><td align="char">92.0</td><td align="char">89.7</td><td align="char">0.088</td><td align="char">1</td><td align="char">.767</td></tr><tr><td>&#x000a0;6-mo follow-up</td><td align="char">84.0</td><td align="char">92.0</td><td align="char">0.758</td><td align="char">1</td><td align="char">.384</td></tr><tr><td>&#x000a0;12-mo follow-up</td><td align="char">94.4</td><td align="char">88.9</td><td align="char">0.364</td><td align="char">1</td><td align="char">.546</td></tr><tr><td>Remitters, %</td><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;Posttreatment</td><td align="char">60.6</td><td align="char">58.8</td><td align="char">0.022</td><td align="char">1</td><td align="char">.882</td></tr><tr><td>&#x000a0;3-mo follow-up</td><td align="char">51.7</td><td align="char">58.1</td><td align="char">0.243</td><td align="char">1</td><td align="char">.622</td></tr><tr><td>&#x000a0;6-mo follow-up</td><td align="char">53.8</td><td align="char">77.8</td><td align="char">3.38</td><td align="char">1</td><td align="char">.066</td></tr><tr><td>&#x000a0;12-mo follow-up</td><td align="char">83.3</td><td align="char">77.8</td><td align="char">0.177</td><td align="char">1</td><td align="char">.674</td></tr></tbody></table><table-wrap-foot><fn><p>Note: Mo = month; TCBT&#x000a0;= telephone cognitive-behavioral therapy.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl2fna"><label>a</label><p>CBT responders&#x000a0;&#x02265;35% Children&#x02019;s Yale&#x02013;Brown Obsessive Compulsive Scale (CY-BOCS) reduction.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl2fnb"><label>b</label><p>Remitters&#x000a0;&#x02264;12 on CY-BOCS.</p></fn></table-wrap-foot></table-wrap></floats-group></article>